Phase II study of weekly albumin-bound paclitaxel combined with cisplatin in patients with advanced breast cancer

被引：0
|
作者：
Hu, X. [1 ]
Wang, B. [1 ]
机构：
[1] Fudan Univ, Canc Hosp, Shanghai 200433, Peoples R China
来源：
BREAST | 2011年 / 20卷
关键词：
D O I：
10.1016/S0960-9776(11)70254-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S77 / S77
页数：1
相关论文
共 50 条
  • [31] Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer
    Polee, MB
    Eskens, FALM
    van der Burg, MEL
    Splinter, TAW
    Siersema, PD
    Tilanus, HW
    Verweij, J
    Stoter, G
    van der Gaast, A
    BRITISH JOURNAL OF CANCER, 2002, 86 (05) : 669 - 673
  • [32] Weekly cisplatin-epirubicin-paclitaxel in advanced breast cancer: A phase I study
    Frasci, G
    Comella, P
    D'Aiuto, G
    Apicella, A
    Thomas, R
    Capasso, I
    Frasci, GG
    Comella, G
    Cortino, GR
    DiBonito, M
    Piccolo, S
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S13 - S13
  • [33] Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer
    M B Polee
    F A L M Eskens
    M E L van der Burg
    T A W Splinter
    P D Siersema
    H W Tilanus
    J Verweij
    G Stoter
    A van der Gaast
    British Journal of Cancer, 2002, 86 : 669 - 673
  • [34] A phase II study of neoadjuvant epirubicin/cyclophosphamide (EC) followed by weekly nanoparticle albumin-bound paclitaxel with or without trastuzumab for node-positive breast cancer
    Hirano, A.
    Hattori, A.
    Kamimura, M.
    Ogura, K.
    Kim, N.
    Setoguchi, Y.
    Okubo, F.
    Inoue, H.
    Jibiki, N.
    Miyamoto, R.
    Kinoshita, J.
    Kimura, K.
    Fujibayashi, M.
    Shimizu, T.
    CANCER RESEARCH, 2012, 72
  • [35] A PILOT NEOADJUVANT STUDY OF SEQUENTIAL NANOPARTICLE ALBUMIN-BOUND PACLITAXEL FOLLOWED BY FEC IN ADVANCED BREAST CANCER
    Ohtani, S.
    Kochi, M.
    Abe, K.
    Sakata, Y.
    Hiraki, K.
    Fujiwara, Y.
    Iwamoto, Y.
    ANNALS OF ONCOLOGY, 2012, 23 : 127 - 127
  • [36] Tolerance, Variability and Pharmacokinetics of Albumin-Bound Paclitaxel in Chinese Breast Cancer Patients
    Li, Qingmei
    Zhang, Hong
    Zhu, Xiaoxue
    Liu, Chengjiao
    Wu, Min
    Li, Cuiyun
    Li, Xiaojiao
    Gao, Lei
    Ding, Yanhua
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [37] A Phase II Trial of Dose-Dense Neoadjuvant Gemcitabine, Epirubicin, and Albumin-Bound Paclitaxel With Pegfilgrastim in the Treatment of Patients With Locally Advanced Breast Cancer
    Yardley, Denise A.
    Zubkus, John
    Daniel, Brooke
    Inhorn, Roger
    Lane, Cassie M.
    Vazquez, Elizabeth R.
    Naot, Yuval
    Burris, Howard A., III
    Hainsworth, John D.
    CLINICAL BREAST CANCER, 2010, 10 (05) : 367 - 372
  • [38] Phase II Study of Weekly Paclitaxel for Advanced or Metastatic Breast Cancer in Japan
    Horiguchi, Jun
    Rai, Yoshiaki
    Tamura, Kazuo
    Taki, Toshihiko
    Hisamatsu, Kazufumi
    Ito, Yoshinori
    Seriu, Taku
    Tajima, Tomoo
    ANTICANCER RESEARCH, 2009, 29 (02) : 625 - 630
  • [39] Nanoparticle albumin-bound paclitaxel for treatment of metastatic breast cancer
    Pinder, Mary C.
    Ibrahim, Nuhad K.
    DRUGS OF TODAY, 2006, 42 (09) : 599 - 604
  • [40] Overview of nanoparticle albumin-bound paclitaxel in metastatic breast cancer
    Strauch, Demetria Ileana
    Moreno-Aspitia, Alvaro
    BREAST CANCER MANAGEMENT, 2013, 2 (03) : 221 - 229
12345